AbCellera Biologics (ABCL) Net Cash Flow (2020 - 2026)
AbCellera Biologics (ABCL) posted Net Cash Flow of -$51.4 million for Q1 2026, down 215.51% on a QoQ basis from $44.5 million in Q4 2025, and down 2286.81% year-over-year from $2.4 million in Q1 2025.
AbCellera Biologics (ABCL) Net Cash Flow (2020 - 2026) Analysis & Trends
AbCellera Biologics' Net Cash Flow history runs 7 years deep, the most recent figure standing at -$51.4 million for Q1 2026.
- Quarterly Net Cash Flow fell 2286.81% year-over-year to -$51.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$83.2 million (down 325.3% YoY) and the FY2025 annual result came in at -$29.5 million, down 214.99% from the prior year.
- Net Cash Flow was -$51.4 million for Q1 2026 at AbCellera Biologics, down from $44.5 million in the prior quarter.
- Across five years, Net Cash Flow topped out at $247.0 million in Q2 2022 and bottomed at -$408.8 million in Q3 2022.
- A 5-year average of -$22.8 million and a median of -$8.7 million in 2025 frame the typical range for Net Cash Flow.
- Annual changes were most pronounced in 2024 — Net Cash Flow jumped 276.17% — and 2026, when it sank 2286.81%.
- AbCellera Biologics' Net Cash Flow stood at $14.2 million in 2022, then tumbled by 382.92% to -$40.2 million in 2023, then jumped by 179.28% to $31.8 million in 2024, then soared by 39.77% to $44.5 million in 2025, then sank by 215.51% to -$51.4 million in 2026.
- Business Quant data shows ABCL's Net Cash Flow at -$51.4 million in Q1 2026, $44.5 million in Q4 2025, and -$8.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 10.56 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 224.46 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.34 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 457.40 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -152.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 57.19 Mn |
| 10 | AbCellera Biologics | 1.72 Bn | 1.72 Bn | - | -51.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -51.41 Mn |
| Mar 31, 2026 | -51.41 Mn |
| Dec 31, 2025 | 44.51 Mn |
| Dec 31, 2025 | 44.51 Mn |
| Sep 30, 2025 | -8.73 Mn |
| Sep 30, 2025 | -8.73 Mn |
| Jun 30, 2025 | -67.59 Mn |
| Jun 30, 2025 | -67.59 Mn |
| Mar 31, 2025 | 2.35 Mn |
| Mar 31, 2025 | 2.35 Mn |
| Dec 31, 2024 | 31.85 Mn |
| Dec 31, 2024 | 31.85 Mn |
| Sep 30, 2024 | -22.04 Mn |
| Sep 30, 2024 | -22.04 Mn |
| Jun 30, 2024 | 24.78 Mn |
| Jun 30, 2024 | 24.78 Mn |
| Mar 31, 2024 | -8.97 Mn |
| Mar 31, 2024 | -8.97 Mn |
| Dec 31, 2023 | -40.17 Mn |
| Dec 31, 2023 | -40.17 Mn |